The Mesenchymal Niche in Myelodysplastic Syndromes

Diagnostics (Basel). 2022 Jul 5;12(7):1639. doi: 10.3390/diagnostics12071639.

Abstract

Myelodysplastic syndromes (MDSs) are clonal disorders characterized by ineffective hematopoiesis, resulting in cytopenias and a risk of developing acute myeloid leukemia. In addition to mutations affecting hematopoietic stem cells (HSCs), numerous studies have highlighted the role of the bone marrow microenvironment (BMME) in the development of MDSs. The mesenchymal niche represents a key component of the BMME. In this review, we discuss the role of the mesenchymal niche in the pathophysiology of MDS and provide an overview of currently available in vitro and in vivo models that can be used to study the effects of the mesenchymal niche on HSCs.

Keywords: hematopoietic stem cell; mesenchymal stromal cells; models; niche.

Publication types

  • Review

Grants and funding

This research received no external funding.